Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Wayne C. Cantwell sold 5,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $11.01, for a total transaction of $55,050.00. Following the sale, the director now directly owns 233,198 shares in the company, valued at $2,567,509.98. This trade represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Arteris Price Performance
Shares of NASDAQ AIP traded up $0.03 during mid-day trading on Monday, reaching $12.28. 495,407 shares of the company were exchanged, compared to its average volume of 869,555. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $12.64. The company's 50 day moving average price is $9.00 and its 200 day moving average price is $8.08. The stock has a market capitalization of $493.37 million, a PE ratio of -12.79 and a beta of 1.17. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Hedge Funds Weigh In On Arteris
A number of hedge funds and other institutional investors have recently modified their holdings of the company. US Bancorp DE purchased a new position in shares of Arteris during the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris during the second quarter valued at approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris during the second quarter worth approximately $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris in the 3rd quarter valued at $226,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Rosenblatt Securities reiterated a "buy" rating and issued a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.
Read Our Latest Stock Analysis on AIP
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
